The United Nations (UN) Sustainable Development Goals (SDGs), launched in 2015, set goals to achieve a sustainable and fair future for people around the world by the year 2030. Since 2016, the State of São Paulo government has been working to institutionalize the 2030 Agenda and the SDGs. Scientific research on these themes makes an important contribution to achieving the goals. As a state sponsoring agency, the São Paulo Research Foundation (FAPESP) is in line with official initiatives in progress and, over time, has offered financial support for scientific, technological and innovation research in this context.
FAPESP Initiatives and Programs for the 2030 Agenda:
FAPESP supports research and development projects for new technologies aimed at combating COVID-19.
In the FAPESP series of COVID-19 Research Webinars, researchers from Brazil and other countries debate the findings and results of studies related to the advancement of knowledge about COVID-19.
The COVID-19 Data Sharing / BR repository is an initiative of FAPESP in cooperation with the University of São Paulo, which gathers demographic data and anonymised clinical and laboratory test results from patients, made available by partner hospitals and laboratories, in order to contribute for research on the disease.
The Research Program on Public Policies supports research projects aimed at meeting concrete social demands.
The Public Education Improvement Program supports research that aims to contribute to improving the quality of public education in the State of São Paulo.
The Research Program for the SUS: Shared Management in Health funds research aimed at solving priority health problems and strengthening the management of the Unified Health System (SUS) in the State of São Paulo.
The Program for the Modernization of State Research Institutese (PDIP) invests in the modernization of the infrastructure and training of personnel from 12 research institutions in São Paulo.
The Centre of Excellence for Research in Sustainable Chemistry (CERSusChem) is an initiative of researchers at the Chemistry Department of the Federal University of São Carlos aiming to promote the development and implementation of green and sustainable chemistry and related technologies. The Center is financed by FAPESP and GSK.
The goal of the Center of Excellence in New Target Discovery (CENTD) is to identify molecular targets and signaling pathways involved in inflammation-based diseases. The idea is to use natural products such as poisons and animal secretions to validate therapeutic targets and pave the way to new drug development. Hosted by the Butantan Institute, the CENTD is funded by FAPESP and GSK.
The major goals of the Center for Innovation in Biodiversity and Drug Discovery (CIBFar) are to perform basic and applied science, as well as the technological development in all the areas of biodiversity and drugs discovery on the basis of research that uses the state of the art of the chemistry of natural products, synthetic organic chemistry, molecular and structural biology, biochemist, medicinal chemistry, drug design and pharmacological assays. CIBFar is a Research, Innovation and Dissemination Center funded by FAPESP and hosted by the University of São Paulo in the city of São Carlos.
Launched in 2013, the Food Research Center (FoRC) is the first Brazilian multidisciplinary research center focused on Food Science and Nutrition. Hosted by the University of São Paulo, the FoRC is one of the Research, Innovation and Dissemination Centers (RIDCs) supported by FAPESP.
The Center for Research on Inflammatory Diseases (CRID) was created with the aim of producing integrative and translational scientific research to identify and validate new biological routes involved in the induction and resolution of inflammation. To this end, it relies on the experience of researchers from various fields of Biomedical Sciences linked to basic research (genetics, molecular and cellular biology, immunology, pharmacology and pathology) and clinical research (rheumatology, immunology, infectology and dermatology), in addition to researchers in the area of bioinformatics. Hosted by the University of São Paulo, in the city of Ribeirão Preto, the CRID is one of the Research, Innovation and Dissemination Centers (RIDCs) supported by FAPESP.
The Obesity and Comorbidities Research Center (OCRC) coordinates scientific efforts to find solutions for obesity, a disease highly associated with a number of serious health problems such as type 2 diabetes, hypertension, atherosclerosis and certain kinds of cancer. The OCRC staff is constantly in contact with the industry and other potential users of the knowledge and products obtained through our researches in order to speed up the transfer of knowledge to society. Hosted by the University of Campinas, the CRID is one of the Research, Innovation and Dissemination Centers (RIDCs) supported by FAPESP.
The Center for Redox Processes in Biomedicine (Redoxoma) is a multidisciplinary network of researchers focused on a concerted approach to investigate redox processes. These processes involve reactions of electron transfer through free radicals or non-radical intermediates, and have a unique potential to elucidate biochemical pathways underlying the physiology of cells and organs, as well as to reveal the mechanisms of disease and therapeutic targets. Hosted by the University of São Paulo, the Redoxoma is one of the Research, Innovation and Dissemination Centers (RIDCs) supported by FAPESP.
The Center of Toxins, Immune-Response and Cell Signaling (CeTICS) mission is to probe into biological systemic response of cells, tissues or whole organisms using chemically defined peptide toxins as molecular tools. Hosted by the Butantan Institute, the CeTICS is a Research, Innovation and Dissemination Centers (RIDCs) supported by FAPESP.
The Human Genome and Stem Cell Research Center (HUG-CELL) conducts research in human and medical genetics, providing genetic counseling service and genetic tests for the population, as well as developing activities related to genetics education and technology transfer. In addition, HUG-CELL develops research on emerging topics that are relevant for society, such as the genetic susceptibility responsible for microcephaly in babies exposed to the zika virus and the current search for germline genetic variants associated with the clinical variability of COVID-19. Hosted by the University of São Paulo, the HUG-CELL is one of the Research, Innovation and Dissemination Centers (RIDCs) supported by FAPESP.
The Research, Innovation and Dissemination Center for Neuromathematics (NeuroMat) is a center of mathematics whose mission is to develop the new mathematics needed to construct a Theory of the Brain accounting for the experimental data gathered by neuroscience research.
The Center for Cell-based Therapy (CTC) is made up of a group of researchers of USP and of the Regional Blood Center of Ribeirão Preto who are interested in understanding the biology of stem cells, as well as in developing new technology for their use in the treatment of diseases. CTC researchers have interest in signaling pathways of mammalian and human embryonic stem cells, in animal and human adult cells reprogramming to the embryonic state of pluripotency and in the functioning of adult stem cells, such as hematopoietic, mesenchymal and cancer stem cells. Hosted by the University of São Paulo, the CTC is one of the Research, Innovation and Dissemination Centers (RIDCs) supported by FAPESP.
The Brazilian Institute of Neuroscience and Neurotechnology (BRAINN) investigates the molecular mechanisms underlying epilepsy and stroke, as well as lesions associated with these diseases. Our studies integrate genetics, neurobiology, pharmacology, neuroimaging, computer science, robotics, physics and engineering, all in a quest to better understand the human brain. Hosted by the University of Campinas, the BRAINN is one of the Research, Innovation and Dissemination Centers (RIDCs) supported by FAPESP.
NPOP / NuTeC - Cell Therapy Center, implemented under the Science for Development program, headquartered at the Hemocentro Foundation of Ribeirão Preto, aims to provide cell therapy and innovative immunotherapies for patients with neoplasms, among other objectives.
NPOP - Multicentric Program Using PSMA Radioligants for the Diagnosis and Therapy of Patients with Prostate Cancer, constituted under the Science for Development program, is headquartered at the Institute for Energy and Nuclear Research (Ipen).
NPOP - Immunobiological Research and Development Center, linked to the Science for Development program, is based at the Butantan Institute.
NPOP / IViS - Innovation for Health Surveillance, established under the Science for Development program, has headquarters at the Disease Control Coordination of the São Paulo Health Department.